UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacologic Opportunities for HIV Prevention

Clinical pharmacology and therapeutics, 2010-11, Vol.88 (5), p.598-609

2010

Volltextzugriff (PDF)

Lopinavir ritonavir Reduces Bupropion Plasma Concentrations in Healthy Subjects

Clinical pharmacology and therapeutics, 2007-01, Vol.81 (1), p.69-75

2007

Volltextzugriff (PDF)

Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates

Clinical pharmacology and therapeutics, 2011-05, Vol.89 (5), p.702-707

2011

Volltextzugriff (PDF)

Development of an LC-MS Method for Measuring TNF in Human Vaginal Tissue

Journal of chromatographic science, 2010-03, Vol.48 (3), p.219-223

2010

Volltextzugriff (PDF)

A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir

Clinical pharmacology and therapeutics, 2010-06, Vol.87 (6), p.735-742

2010

Volltextzugriff (PDF)

Dosing of Aminoglycosides To Rapidly Attain Pharmacodynamic Goals and Hasten Therapeutic Response by Using Individualized Pharmacokinetic Monitoring of Patients with Pneumonia Caused by Gram-Negative Organisms

Antimicrobial Agents and Chemotherapy, 1998-07, Vol.42 (7), p.1842-1844

1998

Volltextzugriff (PDF)

Pharmacokinetics of two common antiretroviral regimens in older HIV‐infected patients: a pilot study

HIV medicine, 2013-08, Vol.14 (7), p.401-409

2013

Volltextzugriff (PDF)

Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria

Antimicrobial Agents and Chemotherapy, 1999-03, Vol.43 (3), p.623-629

1999

Volltextzugriff (PDF)

Antiretroviral-drug concentrations in semen : Implications for sexual transmission of human immunodeficiency virus type 1

Antimicrobial agents and chemotherapy, 1999-08, Vol.43 (8), p.1817-1826

1999

Volltextzugriff (PDF)

Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs

Clinical pharmacokinetics, 1998-03, Vol.34 (3), p.203-218

1998

Volltextzugriff (PDF)

Biological Correlates of Sexual Transmission of HIV Practical Consequences and Potential Targets for Public Health: Practical Consequences and Potential Targets for Public Health

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2002-03, Vol.45 (3), p.277-285

2002

Volltextzugriff (PDF)

Nucleoside Analogues Achieve High Concentrations in Seminal Plasma: Relationship between Drug Concentration and Virus Burden

The Journal of infectious diseases, 1999-12, Vol.180 (6), p.2039-2043

1999

Volltextzugriff (PDF)

Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam

Clinical pharmacology and therapeutics, 1998-09, Vol.64 (3), p.269-277

1998

Volltextzugriff (PDF)

HIV Antiretroviral Postexposure Prophylaxis: A Cautionary Note

Clinical infectious diseases, 2005-11, Vol.41 (10), p.1514-1516

2005

Volltextzugriff (PDF)

Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping

Clinical pharmacology and therapeutics, 1998-09, Vol.64 (3), p.257-268

1998

Volltextzugriff (PDF)

Quantitation of three‐month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N‐acetyltransferase‐2, and xanthine oxidase activity determined with caffeine phenotyping

Clinical pharmacology and therapeutics, 1998-05, Vol.63 (5), p.540-551

1998

Volltextzugriff (PDF)

Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection

World journal of hepatology, 2016-03, Vol.8 (7), p.368-375

2016

Volltextzugriff (PDF)

Legionella urinary antigen testing: Potential impact on diagnosis and antibiotic therapy

Diagnostic microbiology and infectious disease, 1996-03, Vol.24 (3), p.129-139

1996

Volltextzugriff (PDF)

Development and evaluation of a Bayesian pharmacokinetic estimator and optimal, sparse sampling strategies for ceftazidime

Antimicrobial Agents and Chemotherapy, 1996-08, Vol.40 (8), p.1860-1865

1996

Volltextzugriff (PDF)

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method

Pharmacogenetics (London), 2000-07, Vol.10 (5), p.373

2000

Volltextzugriff (PDF)

Biological Correlates of Sexual Transmission of HIV Practical Consequences and Potential Targets for Public Health : Practical Consequences and Potential Targets for Public Health

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2002-03, Vol.45 (3), p.277-285

2002

Volltextzugriff (PDF)

Absence of Effect of Terbinafine on the Activity of CYP1A2, NAT-2, and Xanthine Oxidase

Journal of clinical pharmacology, 1998-05, Vol.38 (5), p.424-428

1998

Volltextzugriff (PDF)

Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping

Pharmacogenetics (London), 1998-10, Vol.8 (5), p.403-410

1998

Volltextzugriff (PDF)

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

Nature (London), 2012-07, Vol.487 (7408), p.482-485

2012

Volltextzugriff (PDF)

Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity

Pharmacogenetics (London), 1999-08, Vol.9 (4), p.453

1999

Volltextzugriff (PDF)

1 – 25 von 382

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(339)
Mit Volltextzugriff
(268)

Publikationsform

Sprache

Englisch
(367)
Russisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pharmacologic Opportunities for HIV Prevention

Lopinavir ritonavir Reduces Bupropion Plasma Concentrations in Healthy Subjects

Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates

Development of an LC-MS Method for Measuring TNF in Human Vaginal Tissue

A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir

Dosing of Aminoglycosides To Rapidly Attain Pharmacodynamic Goals and Hasten Therapeutic Response by Using Individualized Pharmacokinetic Monitoring of Patients with Pneumonia Caused by Gram-Negative Organisms

Pharmacokinetics of two common antiretroviral regimens in older HIV‐infected patients: a pilot study

Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria

Antiretroviral-drug concentrations in semen : Implications for sexual transmission of human immunodeficiency virus type 1

Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs

Biological Correlates of Sexual Transmission of HIV Practical Consequences and Potential Targets for Public Health: Practical Consequences and Potential Targets for Public Health

Nucleoside Analogues Achieve High Concentrations in Seminal Plasma: Relationship between Drug Concentration and Virus Burden

Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam

HIV Antiretroviral Postexposure Prophylaxis: A Cautionary Note

Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping

Quantitation of three‐month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N‐acetyltransferase‐2, and xanthine oxidase activity determined with caffeine phenotyping

Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection

Legionella urinary antigen testing: Potential impact on diagnosis and antibiotic therapy

Development and evaluation of a Bayesian pharmacokinetic estimator and optimal, sparse sampling strategies for ceftazidime

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method

Biological Correlates of Sexual Transmission of HIV Practical Consequences and Potential Targets for Public Health : Practical Consequences and Potential Targets for Public Health

Absence of Effect of Terbinafine on the Activity of CYP1A2, NAT-2, and Xanthine Oxidase

Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity

Suchergebnisse filtern